These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30066646)

  • 21. mixOmics: An R package for 'omics feature selection and multiple data integration.
    Rohart F; Gautier B; Singh A; Lê Cao KA
    PLoS Comput Biol; 2017 Nov; 13(11):e1005752. PubMed ID: 29099853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.
    Brookes ST; Whitley E; Peters TJ; Mulheran PA; Egger M; Davey Smith G
    Health Technol Assess; 2001; 5(33):1-56. PubMed ID: 11701102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of omics techniques in forensic entomology research.
    Shao S; Yang L; Hu G; Li L; Wang Y; Tao L
    Acta Trop; 2023 Oct; 246():106985. PubMed ID: 37473953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epistemological issues in omics and high-dimensional biology: give the people what they want.
    Mehta TS; Zakharkin SO; Gadbury GL; Allison DB
    Physiol Genomics; 2006 Dec; 28(1):24-32. PubMed ID: 16968808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advantages and Pitfalls of Mass Spectrometry Based Metabolome Profiling in Systems Biology.
    Aretz I; Meierhofer D
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27128910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
    Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
    Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-omics integration in biomedical research - A metabolomics-centric review.
    Wörheide MA; Krumsiek J; Kastenmüller G; Arnold M
    Anal Chim Acta; 2021 Jan; 1141():144-162. PubMed ID: 33248648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolomics enables precision medicine: "A White Paper, Community Perspective".
    Beger RD; Dunn W; Schmidt MA; Gross SS; Kirwan JA; Cascante M; Brennan L; Wishart DS; Oresic M; Hankemeier T; Broadhurst DI; Lane AN; Suhre K; Kastenmüller G; Sumner SJ; Thiele I; Fiehn O; Kaddurah-Daouk R;
    Metabolomics; 2016; 12(10):149. PubMed ID: 27642271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A powerful framework for an integrative study with heterogeneous omics data: from univariate statistics to multi-block analysis.
    Duruflé H; Selmani M; Ranocha P; Jamet E; Dunand C; Déjean S
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32778869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New mass spectrometry technologies contributing towards comprehensive and high throughput omics analyses of single cells.
    Couvillion SP; Zhu Y; Nagy G; Adkins JN; Ansong C; Renslow RS; Piehowski PD; Ibrahim YM; Kelly RT; Metz TO
    Analyst; 2019 Jan; 144(3):794-807. PubMed ID: 30507980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting interpretability of metabolome models based on behavior, putative identity, and biological relevance of explanatory signals.
    Enot DP; Beckmann M; Overy D; Draper J
    Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14865-70. PubMed ID: 16990432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Onco-Multi-OMICS Approach: A New Frontier in Cancer Research.
    Chakraborty S; Hosen MI; Ahmed M; Shekhar HU
    Biomed Res Int; 2018; 2018():9836256. PubMed ID: 30402498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Comprehensive "Omics" Approach from Metabolomics to Advanced Omics for Development of Immune Checkpoint Inhibitors: Potential Strategies for Next Generation of Cancer Immunotherapy.
    Yoon SJ; Lee CB; Chae SU; Jo SJ; Bae SK
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leveraging Multilayered "Omics" Data for Atopic Dermatitis: A Road Map to Precision Medicine.
    Ghosh D; Bernstein JA; Khurana Hershey GK; Rothenberg ME; Mersha TB
    Front Immunol; 2018; 9():2727. PubMed ID: 30631320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second Era of OMICS in Caries Research: Moving Past the Phase of Disillusionment.
    Nascimento MM; Zaura E; Mira A; Takahashi N; Ten Cate JM
    J Dent Res; 2017 Jul; 96(7):733-740. PubMed ID: 28384412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simplivariate models: ideas and first examples.
    Hageman JA; Hendriks MM; Westerhuis JA; van der Werf MJ; Berger R; Smilde AK
    PLoS One; 2008 Sep; 3(9):e3259. PubMed ID: 18810272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrative eQTL analysis of tumor and host omics data in individuals with bladder cancer.
    Pineda S; Van Steen K; Malats N
    Genet Epidemiol; 2017 Sep; 41(6):567-573. PubMed ID: 28643332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.
    Tebani A; Afonso C; Marret S; Bekri S
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649151
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.